PillRx only · Injection, Solution · Intravenous
Famotidine
Famotidine
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers6 labelers
Packages15
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.327
Latest avg · Jun 17, 2026
+0%
Since Apr 22, 2026
5
Active US suppliers
71%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it5 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sagent Pharmaceuticals | unknown | 6 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 4 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 2 | SUPPLYING |
| Baxter Healthcare Corporation | unknown | 1 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 1 | SUPPLYING |
| Athenex Pharmaceutical Division, LLC. | unknown | 1 | EXITED 2026 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.